Skip to main content
Premium Trial:

Request an Annual Quote

Agilent's Bio-Analytical Fiscal Q1Revenues Rise 22 Percent as Life Sciences Grows 23 Percent

NEW YORK (GenomeWeb News) — Agilent Technologies said late yesterday that fiscal first-quarter revenues increased 10 percent as R&D spending increased 1.8 percent and profit declined after a divestiture during the same period last year caused the company to report a large gain.
 
Total receipts for the three months ended Jan. 31 increased to $1.25 billion from $1.17 billion year over year.
 
Revenue for the company’s Bio-Analytical Measurement segment increased 22 percent to $455 million from $373 million year over year.   
 
Life Sciences revenue was up 23 percent to $195 million. The company said that growth was “driven by year-end spending in pharmaceutical and biotech,” and sales of the company’s liquid chromatographers.
 
R&D spending increased to $168 million from $165 million year over year.
 
The company said net income decreased to $150 million from $2.09 billion in the year-ago period, which included $1.8 billion in income from the sale of the company’s semiconductor products and services business.
 
Agilent said it had around $2.1 billion in cash and equivalents as of Jan. 31.
 
For the second quarter of 2007, the company said it expects revenues between $1.3 billion and 1.4 billion.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.